Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations
- 14 June 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (27) , 3553-3562
- https://doi.org/10.1038/sj.onc.1204465
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 38 references indexed in Scilit:
- Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4Oncogene, 2000
- FGF Receptor Mutations: Dimerization Syndromes, Cell Growth Suppression, and Animal ModelsIUBMB Life, 2000
- FGF Receptor Mutations: Dimerization Syndromes, Cell Growth Suppression, and Animal ModelsIUBMB Life, 2000
- FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cellsOncogene, 1998
- Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3Nature Genetics, 1997
- Signal Transduction Pathway of Human Fibroblast Growth Factor Receptor 3Published by Elsevier ,1997
- Fibroblast Growth Factor Receptors (FGFRs) Localize in Different Cellular CompartmentsPublished by Elsevier ,1995
- Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3Nature Genetics, 1995
- Robust estimation of structured covariance matricesIEEE Transactions on Signal Processing, 1993
- A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4Genomics, 1991